Related Experiment Video
Updated: Sep 19, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.0K
Continuous Glucose Monitoring in Primary Care: Multidisciplinary Pilot Implementation Study
Alyssa H Zadel1,2, Katia Chiampas3, Katrina Maktaz4
1Division of Cardiology, Northwestern Medicine, Chicago, IL, United States.
JMIR Diabetes
|June 18, 2025
Summary
Primary care physicians can effectively use continuous glucose monitoring (CGM) to improve diabetes management. A multidisciplinary team approach significantly enhanced patient glycemic control and time in range.
Area of Science:
- Endocrinology
- Primary Care Medicine
- Diabetes Management
Background:
- Continuous glucose monitoring (CGM) is crucial for assessing glycemic trends and guiding diabetes treatment.
- Increasing patient access to CGM in primary care settings is a key challenge.
- A multidisciplinary team approach can empower primary care physicians (PCPs) to interpret and utilize CGM data effectively.
Purpose of the Study:
- To evaluate the feasibility and effectiveness of integrating CGM into primary care.
- To assess a multidisciplinary model involving clinical pharmacists and diabetes educators for CGM implementation.
- To determine if PCPs can successfully manage CGM interpretation and patient care adjustments.
Main Methods:
- PCPs received standardized training on CGM interpretation.
- Patients with type 2 diabetes and elevated HbA1c or hypoglycemia concerns were enrolled.
- Physician extenders (PharmD, CDCES) managed CGM device placement, education, and data review, collaborating with PCPs for care plan adjustments.
Main Results:
- Mean time in range significantly increased by 28.06% (43.25% to 71.31%, P<.001).
- Proportion of patients achieving ≥70% time in range rose from 23.81% to 57.14% (P<.001).
- Average HbA1c decreased by 2.37% (9.68% to 7.31%, P<.001).
Conclusions:
- Integrating CGM into primary care via a multidisciplinary team is feasible and effective.
- This approach enhances patient access to CGM and improves glycemic control.
- The model supports PCPs in utilizing CGM for better diabetes management outcomes.
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
2.6K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.6K
Hormones Regulating Blood Glucose
4.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.1K
Pulse rhythm
937
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
937
Hypoglycemia and Glucagon
351
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
351
Diabetes: Management and Pharmacotherapy
410
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
410
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K

